Scale Up of EVs Derived from Probiotic Cells & Their Role in Immuno- Oncology

Time: 4:00 pm
day: Pre-Conference Focus Day


  • Large scale production of EVs derived from attenuated bacterial cells
  • How genetic engineering of these EVs leads to their non-toxic and safe use EVs
  • Oncology applications and T cell stimulation in the tumour microenvironment